Schmitz, N;Nickelsen, M;Ziepert, M;Haenel, M;Borchmann, P;Schmidt, C;Viardot, A;Bentz, M;Peter, N;Ehninger, G;Doelken, G;Ruebe, C;Truemper, L;Rosenwald, A;Pfreundschuh, M;Loeffler, M;Glass, B;German High-Grade Lymphoma Study Group (DSHNHL);Sezer, O;Ordemann, R;Behringer, D;Brossart, P;Fritsch, G;Pflüger, KH;Hänel, M;Peter, N;Levknecht, C;Ehninger, G;Schlegel, F;Dührsen, U;Weidmann, E;Kiehl, M;Giagounidis, A;Trümper, L;Dölken, G;Lindemann, HW;Appel, T;Schmoll, HJ;Bokemeyer, C;Salwender, H;Schmitz, N;Glass, B;Nickelsen, M;Balleisen, H;Kirchner, H;Kirchner, H;Dreger, P;Tron, V;Kaiser, U;Pfreundschuh, M;Kiehl, M;Bentz, M;Kneba, M;Borchmann, P;Frieling, T;Hartmann, F;Fetscher, S;Brosig, B;Hoffmann, J;Fischer, T;Hofmann, WK;Gräven, U;Schmidt, C;Karthaus, M;Peschel, C;Mesters, R;Falge, C;Müller, H;Gaska, T;Maschmeyer, G;Freund, M;Potratz, J;Hähling, D;Gassmann, W;Kölbel, CB;Clemens, M;Kubin, TW;Viardot, A;Frickhofen, N
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).
Lancet Oncol
2012
13
12
1250-9